Score your urinary symptoms, tell us about your health, your sex life and what matters to you, and add any test results you have. You'll see which medicines and procedures fit, which don't, and why. Bring the summary to your own urologist.
Benign prostatic hyperplasia, or BPH, is noncancerous enlargement of the prostate. As the prostate grows, it can narrow the urethra and interfere with bladder emptying. Treatment is individualized according to symptom severity, prostate size and shape, bladder function, medical conditions, medications, and personal priorities.
Evaluation may include a medical history, physical examination, urinalysis, PSA testing when appropriate, a validated symptom questionnaire (the IPSS above), urinary flow measurement, and ultrasound measurement of urine remaining after voiding.
Cystoscopy, prostate imaging, or bladder-function testing (urodynamics) may be recommended for selected patients, and usually before a procedure, so the plan matches your anatomy.
Mild symptoms may be managed with observation, lifestyle changes, or medication. A procedure may be considered when:
No single procedure is right for every prostate. Office-based therapies may offer faster recovery and a greater likelihood of preserving ejaculation, but some patients require retreatment.
Tissue-removing surgery generally produces a larger and more durable urinary channel, with different anesthesia, catheter, bleeding, and sexual side-effect considerations.
Treatment does not always begin with a procedure. These options may improve symptoms, but they do not all work in the same way. Your urologist will consider blood pressure, sexual function, prostate size, bladder symptoms, and other medications before recommending therapy.
| Treatment | How it may help | Common considerations |
|---|---|---|
| Lifestyle changes | Adjusting evening fluids, reducing bladder irritants such as caffeine and alcohol, timed voiding, and reviewing medicines that worsen urination. | Useful for mild symptoms; does not reverse enlargement. |
| Alpha blockers | Relax muscle at the prostate and bladder neck. Examples: tamsulosin, silodosin, alfuzosin, terazosin. | Dizziness, low blood pressure, nasal congestion, or ejaculatory changes. Tell your eye surgeon before cataract surgery. |
| 5-alpha reductase inhibitors | Finasteride and dutasteride gradually shrink larger prostates and reduce the risk of retention or future surgery. | Benefits take months. Sexual side effects and breast tenderness may occur; PSA interpretation changes. |
| Tadalafil | Daily tadalafil may improve urinary symptoms and erectile function in appropriate patients. | Headache, flushing, indigestion, or back pain; cannot be combined with nitrates. |
| Bladder-directed medicines | Antimuscarinic medicines or beta-3 agonists may help urgency and frequency when bladder storage symptoms are prominent. | May worsen retention in some patients. Side effects depend on the medication. |
Many men try saw palmetto and other "prostate health" products first. They are sold without FDA review of whether they work or what is in the bottle, and the American Urological Association guideline does not recommend them for BPH symptoms. Here is what the research shows.
| Remedy | What studies show | Worth knowing |
|---|---|---|
| Saw palmetto | Two large, well-run trials, one at triple the usual dose, found it worked no better than a placebo pill. A Cochrane review reached the same conclusion. | Generally safe. Doesn't meaningfully lower PSA, so it won't hide a PSA rise. |
| Beta-sitosterol | Older, short trials showed some improvement in symptoms and flow. Long-term data are lacking. | Products vary widely in content. |
| Pygeum (African plum) | Small, older trials suggest a modest benefit; quality of evidence is low. | Harvesting has threatened the tree in the wild. |
| Rye grass pollen (Cernilton) | A few small trials show modest symptom improvement. | Avoid with pollen allergies. |
| Pumpkin seed, stinging nettle, lycopene, zinc | Little reliable evidence of benefit for BPH symptoms. | Mostly harmless as food; avoid high-dose zinc. |
| Homeopathic remedies | No reliable evidence of benefit beyond placebo. | Highly diluted products; the main risk is delaying effective treatment. |
If you take any supplement, tell your doctor, especially before a procedure or if you take blood thinners. If symptoms are bothersome, don't let a supplement delay a proper evaluation.
The illustrations show the basic treatment mechanism. They are educational simplifications and do not replace individualized surgical counseling. Manufacturer websites are promotional; they are linked for more detail, not as an endorsement.
These are general patterns rather than guarantees. The most appropriate option depends on prostate anatomy, symptom goals, bladder function, medical risk, and the relative importance of recovery time, durability, and preservation of ejaculation.
| Procedure | How obstruction is relieved | Usual size range | Timing of improvement | Ejaculation |
|---|
Symptom score. The IPSS adds 7 questions scored 0 to 5: 0 to 7 is mild, 8 to 19 moderate, 20 to 35 severe. Questions 2, 4 and 7 measure storage (filling) symptoms; 1, 3, 5 and 6 measure voiding (emptying) symptoms.
Prostate size. From three measurements we use the ellipsoid formula: length × width × height × 0.52. Size ranges for each procedure follow the AUA guideline and device labeling, as listed in the comparison table.
Kidney function. eGFR uses the 2021 CKD-EPI creatinine equation.
PSA. Compared with the same age-specific upper limits used on mypsalevel (Oesterling et al., JAMA 1993): 2.5 in your 40s, 3.5 in your 50s, 4.5 in your 60s and 6.5 ng/mL in your 70s. No age-specific limit is defined under 40 or over 79. Finasteride and dutasteride lower PSA by about half after 6 months, so we double it for comparison. PSA density is PSA divided by prostate volume. For a full PSA risk estimate, use mypsalevel.com.